Iovance Biotherapeutics Inc (IOVA)
R&D Expense Growth
-5.82%
Quarterly · Period ending:
IOVA R&D Expense Growth
Latest reported-5.82%period ending
Latest reported-5.82%period ending
IOVA Quarterly R&D Growth (QoQ) (0.00% → -5.82%)
Latest values, visible window
High-resolution chart · PNG
IOVA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -5.8188% | |
| -12.2411% | |
| -5.2824% | |
| -3.534% | |
| 2.5841% | |
| 5.1797% | |
| 5.8305% | |
| 9.9237% | |
| -22.1839% | |
| -8.7882% | |
| -0.064% | |
| 1.3654% | |
| 4.367% | |
| 2.682% | |
| 11.1321% | |
| -1.2315% | |
| 7.4758% | |
| -9.6752% | |
| 15.7004% | |
| 5.2094% | |
| 11.0279% | |
| 6.6691% | |
| 21.8374% | |
| -12.6314% | |
| -13.4815% | |
| 5.0039% | |
| 30.4362% | |
| 5.812% | |
| 27.1574% | |
| 12.7179% | |
| -1.8929% | |
| 13.8324% | |
| 23.2975% | |
| -3.7882% | |
| 16.5775% | |
| -9.6677% | |
| 18.2278% | |
| 70.6498% | |
| 14.8567% | |
| 90.0291% | |
| 6.4647% | |
| -5.1584% | |
| -11.2984% | |
| 22.855% | |
| 101.6907% | |
| 19.2057% | |
| 376.7166% | |
| -28.3637% | |
| 63.2164% | |
| -45.8921% | |
| 123.7468% | |
| 0% | |
| -7.4074% | |
| 8% | |
| 0% | |
| -7.4074% | |
| -69.526% | |
| -49.5444% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% |